CoChat

Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily1

Open access
Best, J. H., Boye, K. S., Rubin, R. R., Cao, D., Kim, T. H., Peyrot, M. · 2009 · Diabetic Medicine
Cited by 97

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Aims To assess treatment satisfaction and weight‐related quality of life (QOL) in subjects with Type 2 diabetes treated with exenatide once weekly (QW) or twice daily (BID). Methods In this 52‐week randomized, multi‐centre, open‐label study, 295 subjects managed with diet and exercise and/or oral glucose‐lowering medications received either exenatide QW or BID during weeks 1–30; thereafter, subjects receiving exenatide BID were switched to exenatide QW, with 258 total subjects receiving exenatide QW during weeks 30–52. Diabetes Treatment Satisfaction Questionnaire—status (DTSQ‐s) and Impact of Weight on Quality of Life—Lite (IWQOL‐Lite) were assessed at baseline and weeks 30 and 52. Mean group changes from baseline to week 30 were estimated by ancova; changes from week 30 to week 52 were assessed by Student’s t‐test. Results Statistically significant improvements from baseline to week 30 were observed in both treatment groups for DTSQ‐s and IWQOL‐Lite measures, with significantly greater reduction in perceived frequency of hyperglycaemia and greater satisfaction with continuing treatment in the QW group compared with the BID group. Effect sizes for change in DTSQ‐s total scores were 0.84 QW, 0.64 BID; for IWQOL‐Lite: 0.96 QW, 0.82 BID. Treatment satisfaction and QOL improved significantly between weeks 30 and 52 for those switching from BID to QW. Occurrence of adverse events did not affect patients’ improvements in treatment satisfaction and QOL. Conclusions Patients treated with exenatide QW or BID experienced significant and clinically meaningful improvements in treatment satisfaction and QOL. Patients who switched from exenatide BID to exenatide QW administration reported further significant improvements.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2009.02752.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 97

Metadata

Authors
Best, J. H., Boye, K. S., Rubin, R. R., Cao, D., Kim, T. H., & Peyrot, M.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2009-06-30
Volume
26
Issue
7
Pages
722-728
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2065319712
Cited by
97
References
9
FWCI
8.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily1. https://app.cochat.ai/papers/10.1111/j.1464-5491.2009.02752.x
The paper
Best, J. H., Boye, K. S., Rubin, R. R., Cao, D., Kim, T. H., & Peyrot, M. (2009). Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily1. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2009.02752.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.